©The Author(s) 2026.
World J Hepatol. Feb 27, 2026; 18(2): 115763
Published online Feb 27, 2026. doi: 10.4254/wjh.v18.i2.115763
Published online Feb 27, 2026. doi: 10.4254/wjh.v18.i2.115763
Figure 4 Network pharmacology predicts the mechaism of Qushi Huoxue ointment intervention in metabolic associated steatotic liver disease.
A: Venn diagram of traditional Chinese medicine (TCM)-disease-ferroptosis intersection and TCM-disease-autophagy intersection; B: Protein-protein interaction network diagram; C: Gene Ontology enrichment analysis top 10 bar chart, Kyoto Encyclopedia of Genes and Genomes enrichment analysis top 20 bubble chart; D: TCM-component-key target-pathway network diagram; key target-component Sankey diagram. MASLD: Metabolic associated steatotic liver disease; TCM: Traditional Chinese medicine; GO: Gene Ontology; KEGG: Kyoto Encyclopedia of Genes and Genomes.
- Citation: Liu YY, Qin H, Wu HX, Wang RT, Yang QY, Jiang F, Liu XD, Wu DK, Tang YM. Qushi Huoxue ointment ameliorates metabolic associated steatotic liver disease through autophagy activation and ferroptosis inhibition. World J Hepatol 2026; 18(2): 115763
- URL: https://www.wjgnet.com/1948-5182/full/v18/i2/115763.htm
- DOI: https://dx.doi.org/10.4254/wjh.v18.i2.115763